encorafenib,binimetinib
pierre fabre,ono pharma,pfizer
['binimetinib', 'encorafenib', 'nsclc', 'sclc']
#asco23 encorafenib plus binimetinib in patients with brafv600-mutant metastatic nsclc 98 patients
(59 treatment-na ve and 39 previously treated) orr 75% and 46%
mpfs nr vs and 9.3 mo 
Medical Oncologist.                                            
        
On the trail of #SCIENCE to turn cancer into a manageable chronic disease. #bcsm #crcsm